Alkermes Q2 rev $496M, GAAP net income $0.5M; CEO transition to Blair Jackson Aug 1; guidance lowered on CVR charge

Alkermes plc.

Q2 2026 total revenues $496.0M; GAAP net income $0.5M; adjusted EBITDA $139.2M.
Blair Jackson to become CEO on Aug 1, 2026; Richard Pops remains Chairman.
Updated 2026 GAAP net loss guidance widened to ($95M)-($115M) from ($70M)-($90M) due to $26.4M CVR fair value increase.
LUMRYZ net sales $96.6M in Q2, including ~$7M inventory benefit; phase 3 idiopathic hypersomnia data positive.
Cash and investments $691.6M at June 30, 2026, up from $538.2M at March 31, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.